These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30930768)

  • 1. The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson's Disease.
    Lorio S; Sambataro F; Bertolino A; Draganski B; Dukart J
    Front Aging Neurosci; 2019; 11():57. PubMed ID: 30930768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
    Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
    Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.
    Prange S; Metereau E; Maillet A; Lhommée E; Klinger H; Pelissier P; Ibarrola D; Heckemann RA; Castrioto A; Tremblay L; Sgambato V; Broussolle E; Krack P; Thobois S
    Mov Disord; 2019 Nov; 34(11):1644-1654. PubMed ID: 31309609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Brain Network Alteration and its Correlation With Structural Impairments in Patients With Depression in
    Gou L; Zhang W; Li C; Shi X; Zhou Z; Zhong W; Chen T; Wu X; Yang C; Guo D
    Front Neurol; 2018; 9():608. PubMed ID: 30093879
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
    Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
    J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
    Burciu RG; Ofori E; Archer DB; Wu SS; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Brain; 2017 Aug; 140(8):2183-2192. PubMed ID: 28899020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural changes in Parkinson's disease: voxel-based morphometry and diffusion tensor imaging analyses based on
    Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Somehara R; Kamei R; Baba S; Yamaguchi H; Kira JI; Honda H
    Eur Radiol; 2017 Dec; 27(12):5073-5079. PubMed ID: 28677058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
    Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
    J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
    Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
    Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.
    Artzi M; Even-Sapir E; Lerman Shacham H; Thaler A; Urterger AO; Bressman S; Marder K; Hendler T; Giladi N; Ben Bashat D; Mirelman A
    PLoS One; 2017; 12(4):e0175424. PubMed ID: 28406934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.